Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;6(3):80-94.
doi: 10.1007/s40572-019-00232-w.

Mechanisms of Environmental Contributions to Fatty Liver Disease

Affiliations
Review

Mechanisms of Environmental Contributions to Fatty Liver Disease

Banrida Wahlang et al. Curr Environ Health Rep. 2019 Sep.

Abstract

Purpose: Fatty liver disease (FLD) affects over 25% of the global population and may lead to liver-related mortality due to cirrhosis and liver cancer. FLD caused by occupational and environmental chemical exposures is termed "toxicant-associated steatohepatitis" (TASH). The current review addresses the scientific progress made in the mechanistic understanding of TASH since its initial description in 2010.

Recent findings: Recently discovered modes of actions for volatile organic compounds and persistent organic pollutants include the following: (i) the endocrine-, metabolism-, and signaling-disrupting chemical hypotheses; (ii) chemical-nutrient interactions and the "two-hit" hypothesis. These key hypotheses were then reviewed in the context of the steatosis adverse outcome pathway (AOP) proposed by the US Environmental Protection Agency. The conceptual understanding of the contribution of environmental exposures to FLD has progressed significantly. However, because this is a new research area, more studies including mechanistic human data are required to address current knowledge gaps.

Keywords: Endocrine disruption; Polychlorinated biphenyls; Signaling disruption; TASH; Toxicant-associated steatohepatitis; Vinyl chloride.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

Banrida Wahlang, Jian Jin, Juliane I. Beier, Josiah E. Hardesty, Erica F. Daly, Regina D. Schnegelberger, K. Cameron Falkner, Russell A. Prough, Irina A Kirpich, and Matthew C. Cave each declare no potential conflicts of interest.

Figures

Figure 1.
Figure 1.. Selected Modes of Action for Volatile Organic Compounds and Persistent Organic Pollutants in Fatty Liver Disease.
These modes of action are related to the endocrine, metabolism, and signaling disrupting hypotheses as well as nutritional interactions and the two ‘hit’ hypothesis.

Similar articles

Cited by

References

    1. Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: observational study. BMJ. 2018;362:k2817. doi:10.1136/bmj.k2817. - DOI - PMC - PubMed
    1. Fabbrini E, Magkos F. Hepatic Steatosis as a Marker of Metabolic Dysfunction. Nutrients. 2015;7(6):4995–5019. doi:10.3390/nu7064995. - DOI - PMC - PubMed
    1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, Md). 2016;64(1):73–84. doi:10.1002/hep.28431. - DOI - PubMed
    1. Cave M, Falkner KC, Ray M, Joshi-Barve S, Brock G, Khan R et al. Toxicant-associated steatohepatitis in vinyl chloride workers. Hepatology (Baltimore, Md). 2010;51(2):474–81. doi:10.1002/hep.23321. - DOI - PMC - PubMed
    1. Tolman KG, Sirrine R. Occupational Hepatotoxicity. Clin Liver Dis. 1998;2(3):26.

Publication types

MeSH terms